News | Breast Biopsy Systems | February 18, 2026

The Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System is designed to be positioned in the MRI scanner room,

beast biopsy, mri,

Prima MR System (Photo: Mammotome)


Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed to be positioned in the MRI scanner room, at the patient's side during a breast biopsy procedure. This enhances clinician coordination, improves communication and keeps the focus on patient care by bringing the vacuum-assisted breast biopsy device directly into the room.

The Mammotome Prima MR system streamlines workflow with an intuitive in-room design1. Clinicians benefit from larger tissue samples2 enabled by stronger vacuum3 and an 8-gauge needle. This is made possible by 75% less tubing compared to other systems4. Less tubing also results in faster setup and cleanup and less biohazard waste. Additional highlights include convenient aperture size and vacuum strength adjustments on a touchscreen interface.

Ultimately, these combined benefits ensure clinicians can focus on delivering safe, accurate and compassionate care, translating into a better experience for patients. "Our commitment to advancing breast care drives every innovation we bring to market," said Scott Treml, Mammotome Vice President and General Manager. "As the first of its kind in-room solution, the Mammotome Prima MR system empowers clinicians with greater efficiency and confidence, ultimately improving the patient experience."

The Mammotome Prima MR system has secured CE mark, and first cases are underway in select European countries. The system will debut at the European Society of Radiology (ECR) Congress in March. Mammotome will be expanding access in select global markets throughout 2026.

To learn more, please visit the Mammotome website.

References

  1. Compared to the Hologic ATEC system based on a survey of 16/16 (100%) MRI technologists currently using the Hologic ATEC system, after using the Mammotome Prima system.
  2. Mammotome Prima MR 8G probe compared to the Hologic ATEC 9G yielded 78.6% higher average sample weight based on porcine lab data from 120 tissue samples for each group of devices.
  3. Measured at the aperture, compared to the Hologic ATEC breast biopsy system based on benchtop testing.
  4. Compared to the Hologic ATEC standard MR probe tubing and the BD Encor Enspire MR probe with tubing extension.

Related Content

News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
Feature | Magnetic Resonance Imaging (MRI)

The majority of MRI scanners require about 1,500 liters of liquid helium to operate, but geopolitical unrest is putting ...

Time June 17, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
Subscribe Now